Ufp Technologies Inc (UFPT)
- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $286.00
- As of
Kresmion compiles this page from UFPT's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
UFP TECHNOLOGIES INC (UFPT): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-24.
See the full UFPT dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for UFPT on one page. Preview it with sample data, then open it live with a free account.
Preview the UFPT dossierActive events for UFPT
- high13F: large increase
CITADEL ADVISORS LLC added +456% to UFPT (2026Q2)
- high13F: large reduction
TWO SIGMA INVESTMENTS, LP cut 61% of UFPT (2026Q2)
- mediumEarnings above estimates
Q2-2026: Beat consensus by 14.7%, EPS $2.92 vs $2.5449 estimate
- mediumEarnings above estimates
Q1-2026: Beat consensus by 8.2% - EPS $2.48 vs $2.2925 estimate
- mediumEarnings above estimates
Q4-2025: Beat consensus by 5.5% - EPS $2.25 vs $2.1328 estimate
FREE, NO ACCOUNT
Every event on UFPT, as it fires
New filings, 13F moves and cross asset events on UFPT land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in UFPT (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 902673102 · 2026Q2 | $22.4M | 0.03% | , |
| Point72 Asset Management, L.P.CUSIP 902673102 · 2026Q2 | $5.7M | 0.01% | , |
| CITADEL ADVISORS LLCCUSIP 902673102 · 2026Q2 | $2.1M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 902673102 · 2026Q2 | $807K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, UFPT
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
UFPT against its peers
UFPT's operating margin of 15.3% ranks in the 93rd percentile of 20 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-28 and 2026-05-31.
| Metric | UFPT | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 603M USD | 231M USD | 69 | 20 |
| Gross margin | 28.3% | 64.4% | 3 | 19 |
| Operating margin | 15.3% | -17.5% | 93 | 20 |
| Net margin | 11.3% | -13.6% | 83 | 20 |
| Return on equity | 16.1% | -11.4% | 98 | 19 |
| P / E | 32.7x | 29.2x | 58 | 5 |
Peers (20): BFLY, ESTA, NEOG, AXGN, ENOV, AVNS.D, AORT, CBLL, BBNX, SIBN, QDEL, IART, INMD, KIDS, TCMD, DCTH, SSII, BIO, MASS, RCEL. Left out: ALMR (no annual filing), OSSUY (no annual filing), NHNKF (no annual filing), LMRI (no annual filing), BWAY (period gap). Fiscal periods ending between 2025-12-28 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (UFPT: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow UFPT on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to UFPT for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.